FDA Inspection 695835 — Teva Pharmaceutical Industries

Teva Pharmaceutical Industries — FEI 3005202697

The FDA completed an inspection of Teva Pharmaceutical Industries on Sep 16, 2010 in Jerusalem. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 16, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jerusalem (Israel)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.